Scleral lenses are widely used for therapeutic purposes. This case report aims to emphasize the advantages of utilizing scleral lenses as a nonsurgical management option and presents evidence of their effectiveness in improving UCVA from 2/60 to 6/12 and reducing the corneal neovascularization and a hazy interface in a patient with partial limbal stem cell deficiency (LSCD) secondary to chemical injury. This case report highlights the potential of the scleral lens if given with an ideal fit and close monitoring for LSCD caused by chemical injury.
No takes yet. Share an insight, caveat, or question.
Subramanian et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: